Inactive Instrument

Insiders Cytosorbents Corp OTC Bulletin Board

Equities

US23283X2062

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

05-09	Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M	MT
05-09	Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytosorbents Reappoints Kathleen Bloch as Finance Chief	19/09/23	MT
Cytosorbents Corporation Announces Appointment of Kathleen Bloch as Full-Time CFO	18/09/23	CI
Cytosorbents Reports Resignation of CFO D'Amico	01/09/23	MT
Cytosorbents Corporation Announces Resignation of Alexander D?Amico as Chief Financial Officer, Effective August 28, 2023	01/09/23	CI
Cytosorbents Names Alexander D'Amico CFO	19/07/23	MT
CytoSorbents Corporation Appoints Alexander D'Amico as Chief Financial Officer	19/07/23	CI
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial	07/07/23	CI
Cytosorbents Corporation Announces Retirement of Al W. Kraus as A Member of Board	20/04/23	CI
Cytosorbents Corporation Appoints Irina B. Kulinets as Senior Vice President of Global Regulatory Affairs	17/01/23	CI
Cytosorbents Chief Financial Officer Kathleen Bloch to Retire in March	07/10/22	MT
Cytosorbents Corporation Hires Shaun Whittemore as Country Manager - UK & Ireland	14/04/22	CI
Cytosorbents Corporation Appoints Jiny Kim to its Board of Directors	05/04/22	CI
CytoSorbents Corporation Appoints Terri Anne Powers as Vice President of Investor Relations and Corporate Communications	01/06/21	CI
Cytosorbents Corporation Appoints James Komsa as Vice President – U.S. Sales and Marketing	05/05/21	CI
Cytosorbents Corporation Appoints David D. Cox, Ph.D., M.B.A. as Vice President - Global Regulatory Affairs	21/01/21	CI
CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and Marketing	17/12/20	CI
CytoSorbents Promotes Vincent J. Capponi to President and COO	04/05/20	CI
CytoSorbents Corporation Appoints Efthymios N. Deliargyris as Chief Medical Officer, Effective on May 1, 2020	27/04/20	CI
Cytosorbents Corporation Announces Resignation of Eric Mortensen as Chief Medical Officer, Effective December 31, 2019	12/12/19	CI
Eric Mortensen, Chief Medical Officer, to Leave Cytosorbents Corporation	06/11/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cytosorbents Corp OTC Bulletin Board

Equities

US23283X2062

Insiders

Filters